Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study.

Djamali A, Singh T, Melamed ML, Stein JH, Aziz F, Parajuli S, Mohamed M, Garg N, Mandelbrot D, Wesson DE, Astor BC.

Am J Kidney Dis. 2019 Apr;73(4):476-485. doi: 10.1053/j.ajkd.2018.12.023. Epub 2019 Jan 28.

PMID:
30704880
2.

The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Melamed ML, Chonchol M, Gutiérrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R.

Am J Kidney Dis. 2018 Dec;72(6):834-845. doi: 10.1053/j.ajkd.2018.06.031. Epub 2018 Oct 5.

PMID:
30297082
3.

Exploring the Association of Asthma with Urinary Stone Disease: Results from the National Health and Nutrition Examination Survey 2007-2014.

Lee JA, Abramowitz MK, Kipperman N, Drzewiecki BA, Melamed ML, Stern JM.

Eur Urol Focus. 2018 Aug 7. pii: S2405-4569(18)30219-0. doi: 10.1016/j.euf.2018.07.035. [Epub ahead of print]

PMID:
30097392
4.

Metabolic Changes with Base-Loading in CKD.

Scialla JJ, Brown L, Gurley S, Corcoran DL, Bain JR, Muehlbauer MJ, O'Neal SK, M O'Connell T, Wolf M, Melamed ML, Hostetter TH, Abramowitz MK.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1244-1246. doi: 10.2215/CJN.01830218. Epub 2018 Jun 22. No abstract available.

PMID:
29934431
5.

Discharge service as a determinant of 30-day readmission in a cohort of maintenance hemodialysis patients: a retrospective cohort study.

Golestaneh L, Bellin E, Southern W, Melamed ML.

BMC Nephrol. 2017 Dec 4;18(1):352. doi: 10.1186/s12882-017-0761-9.

6.

New Frontiers in Treating Uremic Metabolic Acidosis.

Brown D, Melamed ML.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):4-5. doi: 10.2215/CJN.11771017. Epub 2017 Nov 4. No abstract available.

7.

Seasonality of mortality and graft failure among kidney transplant recipients in the US - a retrospective study.

Astor BC, Melamed ML, Mandelbrot DA, Djamali A.

Transpl Int. 2018 Mar;31(3):293-301. doi: 10.1111/tri.13047. Epub 2017 Sep 26.

8.

Resizing Nephrology Training Programs: A Call to Action.

Melamed ML, Campbell KN, Nickolas TL.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1718-1720. doi: 10.2215/CJN.04740517. Epub 2017 Aug 24. No abstract available.

9.

Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.

Shafi T, Sirich TL, Meyer TW, Hostetter TH, Plummer NS, Hwang S, Melamed ML, Banerjee T, Coresh J, Powe NR.

Kidney Int. 2017 Dec;92(6):1484-1492. doi: 10.1016/j.kint.2017.05.012. Epub 2017 Jul 21.

10.

Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels.

Buttar RS, Batra J, Kreimerman J, Aleta M, Melamed ML.

J Gen Intern Med. 2017 Oct;32(10):1156-1159. doi: 10.1007/s11606-017-4115-x. Epub 2017 Jul 13.

11.

Association of Albuminuria With Cardiac Dysfunction in US Hispanics/Latinos.

Hanna DB, Xu S, Melamed ML, Gonzalez F 2nd, Allison MA, Bilsker MS, Hurwitz BE, Kansal MM, Schneiderman N, Shah SJ, Kaplan RC, Rodriguez CJ, Kizer JR.

Am J Cardiol. 2017 Jun 15;119(12):2073-2080. doi: 10.1016/j.amjcard.2017.03.039. Epub 2017 Mar 29.

12.

The Essential Role for Laboratory Studies in Atmospheric Chemistry.

Burkholder JB, Abbatt JP, Barnes I, Roberts JM, Melamed ML, Ammann M, Bertram AK, Cappa CD, Carlton AG, Carpenter LJ, Crowley JN, Dubowski Y, George C, Heard DE, Herrmann H, Keutsch FN, Kroll JH, McNeill VF, Ng NL, Nizkorodov SA, Orlando JJ, Percival CJ, Picquet-Varrault B, Rudich Y, Seakins PW, Surratt JD, Tanimoto H, Thornton JA, Tong Z, Tyndall GS, Wahner A, Weschler CJ, Wilson KR, Ziemann PJ.

Environ Sci Technol. 2017 Mar 7;51(5):2519-2528. doi: 10.1021/acs.est.6b04947. Epub 2017 Feb 17.

13.

Vascular access placement in patients with chronic kidney disease Stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.

Goel N, Kwon C, Zachariah TP, Broker M, Folkert VW, Bauer C, Melamed ML.

BMC Nephrol. 2017 Jan 17;18(1):28. doi: 10.1186/s12882-016-0431-3.

14.

Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.

Shafi T, Hostetter TH, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J, Powe NR.

Am J Kidney Dis. 2017 Jul;70(1):48-58. doi: 10.1053/j.ajkd.2016.10.033. Epub 2017 Jan 12.

15.

Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.

Kosk D, Kramer H, Luke A, Camacho P, Bovet P, Rhule JP, Forrester T, Wolf M, Sempos C, Melamed ML, Dugas LR, Cooper R, Durazo-Arvizu R.

J Bone Miner Metab. 2017 Nov;35(6):666-674. doi: 10.1007/s00774-016-0804-5. Epub 2016 Dec 9.

16.

FGF-23 and cardiovascular disease: review of literature.

Batra J, Buttar RS, Kaur P, Kreimerman J, Melamed ML.

Curr Opin Endocrinol Diabetes Obes. 2016 Dec;23(6):423-429. Review.

PMID:
27652999
17.

Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study.

Chen W, Melamed ML, Hostetter TH, Bauer C, Raff AC, Almudevar AL, Lalonde A, Messing S, Abramowitz MK.

BMC Nephrol. 2016 Aug 5;17(1):114. doi: 10.1186/s12882-016-0331-6.

18.

Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.

Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J, Hostetter TH.

J Am Soc Nephrol. 2017 Jan;28(1):321-331. doi: 10.1681/ASN.2016030374. Epub 2016 Jul 19.

19.

CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?

Melamed ML, Buttar RS, Coco M.

Adv Chronic Kidney Dis. 2016 Jul;23(4):262-9. doi: 10.1053/j.ackd.2016.03.008. Review.

20.

Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos.

Franceschini N, Deng Y, Flessner MF, Eckfeldt JH, Kramer HJ, Lash JP, Lee DJ, Melamed ML, Moncrieft AE, Ricardo AC, Rosas SE, Kaplan RC, Raij L, Cai J.

Nephrol Dial Transplant. 2016 Oct;31(10):1670-6. doi: 10.1093/ndt/gfw210. Epub 2016 Jun 2.

21.

Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010.

Sarathy H, Henriquez G, Abramowitz MK, Kramer H, Rosas SE, Johns T, Kumar J, Skversky A, Kaskel F, Melamed ML.

PLoS One. 2016 May 25;11(5):e0153588. doi: 10.1371/journal.pone.0153588. eCollection 2016.

22.

The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation.

Calp-Inal S, Ajaimy M, Melamed ML, Savchik C, Masiakos P, Colovai A, Akalin E.

Kidney Int. 2016 Jan;89(1):209-16. doi: 10.1038/ki.2015.275. Epub 2016 Jan 4.

PMID:
26535999
23.

Vitamin D and Clinical Outcomes in Dialysis.

Parikh C, Gutgarts V, Eisenberg E, Melamed ML.

Semin Dial. 2015 Nov-Dec;28(6):604-9. doi: 10.1111/sdi.12446. Epub 2015 Oct 1. Review.

24.

Prevalence and Correlates of CKD in Hispanics/Latinos in the United States.

Ricardo AC, Flessner MF, Eckfeldt JH, Eggers PW, Franceschini N, Go AS, Gotman NM, Kramer HJ, Kusek JW, Loehr LR, Melamed ML, Peralta CA, Raij L, Rosas SE, Talavera GA, Lash JP.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1757-66. doi: 10.2215/CJN.02020215. Epub 2015 Sep 28.

25.

Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.

Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, Furth SL, Warady BA, Portale AA, Melamed ML.

Pediatr Nephrol. 2016 Jan;31(1):121-9. doi: 10.1007/s00467-015-3190-7. Epub 2015 Aug 26.

26.

Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.

Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML.

Am J Nephrol. 2015;42(1):25-34. doi: 10.1159/000438999. Epub 2015 Aug 20.

27.

Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.

Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, Banerjee T, Coresh J, Powe NR.

PLoS One. 2015 May 4;10(5):e0126048. doi: 10.1371/journal.pone.0126048. eCollection 2015.

28.

Vascular calcification in predialysis CKD: common and deadly.

Chen W, Melamed ML.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):551-3. doi: 10.2215/CJN.01940215. Epub 2015 Mar 13. No abstract available.

29.

The effects of short-term vitamin D supplementation on glucose metabolism in dialysis patients: a systematic review and meta-analysis.

Sarathy H, Pramanik V, Kahn J, Abramowitz MK, Meier K, Kishore P, Melamed ML.

Int Urol Nephrol. 2015 Mar;47(3):537-49. doi: 10.1007/s11255-015-0909-0. Epub 2015 Jan 31. Review.

30.

Calcium supplementation increases blood creatinine concentration in a randomized controlled trial.

Barry EL, Mott LA, Melamed ML, Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA.

PLoS One. 2014 Oct 15;9(10):e108094. doi: 10.1371/journal.pone.0108094. eCollection 2014.

31.

Serum bicarbonate and bone mineral density in US adults.

Chen W, Melamed ML, Abramowitz MK.

Am J Kidney Dis. 2015 Feb;65(2):240-8. doi: 10.1053/j.ajkd.2014.07.007. Epub 2014 Aug 29.

32.

Genetics: Vitamin D and blood pressure--a preliminary verdict.

Melamed ML, Manson JE.

Nat Rev Endocrinol. 2014 Oct;10(10):579-80. doi: 10.1038/nrendo.2014.149. Epub 2014 Aug 26. No abstract available.

PMID:
25155297
33.

Medication adherence in the transition of adolescent kidney transplant recipients to the adult care.

Akchurin OM, Melamed ML, Hashim BL, Kaskel FJ, Del Rio M.

Pediatr Transplant. 2014 Aug;18(5):538-48. doi: 10.1111/petr.12289. Epub 2014 May 13.

34.

Vitamin D and kidney disease: what we know and what we do not know.

Inda Filho AJ, Melamed ML.

J Bras Nefrol. 2013 Oct-Dec;35(4):323-31. doi: 10.5935/0101-2800.20130051. Review.

35.

Individuals with exceptional longevity manifest a delayed association between vitamin D insufficiency and cognitive impairment.

Milman S, Schulder-Katz M, Deluty J, Zimmerman ME, Crandall JP, Barzilai N, Melamed ML, Atzmon G.

J Am Geriatr Soc. 2014 Jan;62(1):153-8. doi: 10.1111/jgs.12601. Epub 2014 Jan 2.

36.

Role of vitamin D receptor activation in racial disparities in kidney disease outcomes.

Essien U, Goel N, Melamed ML.

Semin Nephrol. 2013 Sep;33(5):416-24. doi: 10.1016/j.semnephrol.2013.07.003. Review.

37.

Vitamin D, race, and risk for anemia in children.

Atkinson MA, Melamed ML, Kumar J, Roy CN, Miller ER 3rd, Furth SL, Fadrowski JJ.

J Pediatr. 2014 Jan;164(1):153-158.e1. doi: 10.1016/j.jpeds.2013.08.060. Epub 2013 Oct 8.

38.

The authors reply.

Abramowitz MK, Hostetter TH, Melamed ML.

Kidney Int. 2013 Aug;84(2):414-5. doi: 10.1038/ki.2013.183. No abstract available.

39.

Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators.

Melamed ML, Plantinga L, Shafi T, Parekh R, Meyer TW, Hostetter TH, Coresh J, Powe NR.

BMC Nephrol. 2013 Jun 27;14:134. doi: 10.1186/1471-2369-14-134.

40.

A zebrafish model for uremic toxicity: role of the complement pathway.

Berman N, Lectura M, Thurman J, Reinecke J, Raff AC, Melamed ML, Reinecke J, Quan Z, Evans T, Meyer TW, Hostetter TH.

Blood Purif. 2013;35(4):265-269. doi: 10.1159/000348456. Epub 2013 May 8.

41.

Effects of oral sodium bicarbonate in patients with CKD.

Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH.

Clin J Am Soc Nephrol. 2013 May;8(5):714-20. doi: 10.2215/CJN.08340812. Epub 2013 Feb 7.

42.

The serum anion gap is altered in early kidney disease and associates with mortality.

Abramowitz MK, Hostetter TH, Melamed ML.

Kidney Int. 2012 Sep;82(6):701-9. doi: 10.1038/ki.2012.196. Epub 2012 May 23.

43.

Family history of exceptional longevity is associated with lower serum uric acid levels in Ashkenazi Jews.

Lai JY, Atzmon G, Melamed ML, Hostetter TH, Crandall JP, Barzilai N, Bitzer M.

J Am Geriatr Soc. 2012 Apr;60(4):745-50. doi: 10.1111/j.1532-5415.2012.03902.x. Epub 2012 Mar 16.

44.

Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults.

Abramowitz MK, Hostetter TH, Melamed ML.

Kidney Int. 2012 May;81(10):1033-1042. doi: 10.1038/ki.2011.479. Epub 2012 Feb 1.

45.

25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files.

Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharrett AR, Melamed ML.

Nutrition. 2012 Apr;28(4):367-71. doi: 10.1016/j.nut.2011.10.015. Epub 2012 Jan 20.

46.

Vitamin D therapy in chronic kidney disease and end stage renal disease.

Melamed ML, Thadhani RI.

Clin J Am Soc Nephrol. 2012 Feb;7(2):358-65. doi: 10.2215/CJN.04040411. Epub 2011 Dec 22. Review.

47.

Treatment of chronic kidney disease.

Turner JM, Bauer C, Abramowitz MK, Melamed ML, Hostetter TH.

Kidney Int. 2012 Feb;81(4):351-62. doi: 10.1038/ki.2011.380. Epub 2011 Dec 14. Review.

48.

Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006.

Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML.

J Clin Endocrinol Metab. 2011 Dec;96(12):3838-45. doi: 10.1210/jc.2011-1600. Epub 2011 Sep 28.

49.

Vitamin D and cardiovascular disease and cancer: not too much and not too little? The need for clinical trials.

Melamed ML, Manson JE.

Womens Health (Lond). 2011 Jul;7(4):419-24. doi: 10.2217/whe.11.18. Review.

50.

Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis.

Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS.

Cardiol Rev. 2011 Jul-Aug;19(4):192-201. doi: 10.1097/CRD.0b013e31821da9a5. Review. Erratum in: Cardiol Rev. 2011 Sep-Oct;19(5):263.

PMID:
21646873

Supplemental Content

Loading ...
Support Center